The North America feed vitamin market is estimated to reach USD 1.59 billion by 2023 from USD 1.49 billion in 2018 by growing at a CAGR of 1.39 %. North America vitamin feed market stands after Asia Pacific and Europe. US holds the largest share in the region followed by Canada. Dominance of US is because of its large geographical size, economy and favorable climatic conditions.
Animal feed vitamins are given to the livestock for enhancing their diets. Deficiency of vitamins can cause several diseases along with restricted growth of animals and vitamin feed fulfills the deficiency. These are given to the animals for improving their health and obtaining good yield of products like meat, egg and milk. Vitamin A, D, E and B are the major vitamins required through feed.
There are various factors which drives the market such as awareness regarding health, high income, rise in demand for high quality meat and many others. There is a shift observed in consumers towards these types of feed which is also driving the market. The only restrain for the market is high cost of these feeds as the raw materials are also costly.
Mainly the feed vitamin market is segmented into type of livestock including swine, ruminants, poultry, aquatic animals and others. They are either single functioned or multi functioned. On the basis of formulation, they are divided into liquid, dry and others (powder, pellet). Poultry is the largest and fastest growing segment due to increase in population and hence increase in the demand of meant and egg.
Key players in the market are S.A.S, Aland BASF SE, CSPC Pharmaceutical Group Ltd., Zhejiand Medicine company Ltd., Pharmative LLC, North China pharmaceutical corporation, Archer Daniels Midland company, Evonik industries and DSM N.V.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Vitamin Type
5.1.1 Vitamin A
5.1.2 Vitamin B
5.1.3 Vitamin C
5.1.4 Vitamin D
5.1.5 Vitamin E
5.1.6 Vitamin K
5.2 By Livestock Type
5.2.1 Swine
5.2.2 Ruminants
5.2.3 Poultry
5.2.4 Aquatic Animals
5.2.5 Others
5.3 By Formulation
5.3.1 Liquid
5.3.2 Dry
5.3.3 Others (Powder, Pellet)
5.4 By Function
5.4.1 Single Functioned
5.4.2 Multi Functioned
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 S.A.S
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Aland BASF SE
8.3 CSPC Pharmaceutical Group Ltd.
8.4 Zhejiand Medicine Company Ltd.
8.5 Pharmative LLC
8.6 North China pharmaceutical Corporation
8.7 Archer Daniels Midland Company
8.8 Evonik industries
8.9 DSM N.V.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
